IdiopathicPulmonaryfibrosis相关论文
免疫细胞如巨噬细胞、中性粒细胞、嗜酸粒细胞和淋巴细胞等是机体抵御外来病原体入侵的先行军，在早期急性炎症和后期损伤修复中均发......
特发性肺纤维化(IPF)是一种慢性、进行性且最终致命的肺纤维化疾病，其病理特征包括肌成纤维细胞的积累和肺组织中细胞外基质沉积的......
Idiopathic pulmonary fibrosis (IPF) is an aging-associated disease with a poor prognosis.Emerging evidence has revealed ......
Objective:To evaluate the effectiveness and safety of Chinese medicine (CM) for Idiopathic pulmonary fibrosis (IPF) pati......
目的 Idiopathic Pulmonary Fibrosis(IPF) epidemiological studies analyzing have been done in south-western world,but few ......
Efficacy and adverse events of pirfenidone in the treatment of idiopathic pulmonary fibrosis: a syst
目的 To summarize the evidence of PFD for the treatment of IPF.To assess efficacy and adverse events, and provide releva......
目的 The purpose of this review was to delineate our current knowledge of the close relationship between the Idiopathic ......
目的 Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with less effective therapy.Pulmonary rehabilitat......
Effects of VEGF, ET-1 and 6-Keto-PGF1α between Herba Ephedrae and Fructus Schisandrae in rats with p
Aim: To observe differences between Herba Ephedrae and Fructus Schisandrae on the angiogenesis for treating rat idiopath......
Acute exacerbation of idiopathic pulmonary fibrosis: usual interstitial pneumonitis vs. possible usu
...
...
Incidence and Clinical Characteristics of Pulmonary Hypertension in Patients with Idiopathic Pulmona
...
...
...
Expression of suppressor of cytokine signaling 1 in the peripheral blood of patients with idiopathic
...
目的探讨特发性肺纤维化(IPF)临床特点、多层螺旋CT(MSCT)表现特征、肺功能检测结果,并对其进行危险因素分析,寻找MSCT征象及肺功......
特发性肺纤维化是一种原因不明、以弥漫性肺泡炎和肺泡结构紊乱最终导致肺间质纤维化为特征的疾病.西医对此病治疗方法单一,疗效一......
目的：探究干扰素γ（ IFN－γ）联合肝素对特发性肺间质纤维化（ IPF）患者肺功能指标及凝血功能的影响。方法选择2014年1月至2015年5月彭州市......
目的 探讨丹红注射液治疗特发性肺纤维化的临床疗效。方法84例特发性肺纤维化患者，按数字表法随机将其分为对照组（泼尼松治疗）和观察......
目的探讨血管生成素-1、-2（Ang-1、Ang-2）与特发性肺纤维化（IPF）患者临床指标的关系，评估Ang-1、Ang-2对IPF患者预后的预测价值。方法采......
目的评价吡非尼酮治疗特发性肺间质纤维化(IPF)的安全性。方法以“吡非尼酮”“特发性肺间质纤维化”“pirfenidone”“idiopathic......
目的：探究重组人干扰素-γ与泼尼松联用治疗特发性肺间质纤维化的应用价值。方法选取从2012年1月至2015年1月在我院进行治疗的特发......
目的 探讨特发性肺纤维化(IPF)患者血清多种肿瘤标志物含量的变化及其临床意义.方法 采用化学发光法检测25例IPF患者(IPF组)和23例......
目的 探讨N-乙酰半胱氨酸治疗特发性肺间质纤维化( IPF)的效果.方法 将40例患者随机分为试验组和对照组,每组20例,试验组在口服常......
